These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6334939)

  • 1. The pathogenesis of arthritis in Lyme disease: humoral immune responses and the role of intra-articular immune complexes.
    Hardin JA; Steere AC; Malawista SE
    Yale J Biol Med; 1984; 57(4):589-93. PubMed ID: 6334939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
    Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of circulating immune complexes in rheumatoid arthritis: comparison of 2 immunoenzyme methods].
    Bernardoni R; Soffritti E; Pelizzola D; Pazzi A; Accardo G
    Riv Emoter Immunoematol; 1985; 32(1):58-68. PubMed ID: 3909362
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity.
    Hardin JA; Steere AC; Malawista SE
    N Engl J Med; 1979 Dec; 301(25):1358-63. PubMed ID: 503166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
    Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
    J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes and complement in rheumatoid arthritis.
    Lambert PH; Casali P; Nydegger U
    Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.
    Westedt ML; Daha MR; de Vries E; Valentijn RM; Cats A
    J Rheumatol; 1985 Jun; 12(3):449-55. PubMed ID: 4045842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of complement-fixing rheumatoid synovial fluid immune complexes.
    Male DK; Roitt IM
    Clin Exp Immunol; 1981 Dec; 46(3):521-9. PubMed ID: 7337979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1 inactivator-C1s complexes in inflammatory joint disease.
    Inman RD; Harpel PC
    Clin Exp Immunol; 1983 Sep; 53(3):521-8. PubMed ID: 6604603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demonstration and analysis of immune complexes in rheumatic diseases].
    Rosenthal M; Graf U; Müller W
    Schweiz Med Wochenschr; 1976 Aug; 106(33):1116-21. PubMed ID: 1087456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
    Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
    Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is the demonstration of immune complex useful in the activity assessment of chronic polyarthritis?].
    Schlumpf U; Ernst R; Christen P; von Felten A; Böni A
    Schweiz Med Wochenschr; 1984 Jan; 114(4):118-30. PubMed ID: 6367028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of lysozyme on the circulating level of immune complexes in patients with rheumatoid arthritis].
    Di Matteo L; Bosica D; Consoli G; Anichini M
    Boll Soc Ital Biol Sper; 1985 May; 61(5):783-6. PubMed ID: 3875357
    [No Abstract]   [Full Text] [Related]  

  • 19. Demonstration of C1q - binding to collagen - anticollagen immune complexes in synovial fluids of RA-patients.
    Menzel J; Steffen C
    Z Rheumatol; 1982; 41(2):47-9. PubMed ID: 6285637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of complement components C3 and factor B in synovial fluids.
    Hunder GG; McDuffie FC; Mullen BJ
    J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.